This topic contains a solution. Click here to go to the answer

Author Question: Which of the following statements appropriately describes cognitive impairments in individuals with ... (Read 20 times)

pragya sharda

  • Hero Member
  • *****
  • Posts: 566
Which of the following statements appropriately describes cognitive impairments in individuals with major depressive disorder?
 
  a) Every individual diagnosed with major depressive disorder shows at least some impairment.
  b) The deficits are minor and occur only when the individual is experiencing a depressive episode.
  c) The most typical impairment of this disorder is related to spatial ability. .
  d) The onset of these deficits is sudden and irreversible.
  e) Impairments that are seen in individuals with major depressive disorder are markedly different than those seen in individual with schizophrenia.

Question 2

Which of the following structures does not show abnormal activity during imaging studies of depressed individuals?
 
  a) posterior parietal cortex
  b) amygdala
  c) dorsal prefrontal cortex
  d) anterior cingulate



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ambernicolefink

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

Answer: B

Answer to Question 2

Answer: A





 

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library